Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;45(10):2941-2949.
doi: 10.1007/s00261-018-1838-z.

Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion

Francesco Prampolini  1 , Stefania Taschini  2 , Annarita Pecchi  2 , Francesco Sani  2 , Andrea Spallanzani  3 , Fabio Gelsomino  3 , Shaniko Kaleci  4 , Pietro Torricelli  2
Affiliations

Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion

Francesco Prampolini et al. Abdom Radiol (NY). 2020 Oct.

Abstract

Purpose: To evaluate the role of magnetic resonance imaging (MRI) performed before and after neoadjuvant chemoradiotherapy (nCRT) in predicting risk of recurrence in rectal cancer and to investigate the prognostic significance of MR-detected extramural venous invasion (mr-EMVI) and of its regression after nCRT.

Methods: During 2005-2016, 87 patients with rectal cancer underwent pre- and post-nCRT MRI before surgery. Two radiologists independently reviewed MR examinations retrospectively, assessing T stage, nodal involvement, circumferential resection margin (CRM) status, and mr-EMVI. All four parameters assessed in pre- and post-nCRT MRI were correlated with the risk of recurrence. Correlation with disease-free survival (DFS) was investigated for significant predictive factors in pre-nCRT MRI and for mr-EMVI and its possible regression in post-nCRT MRI.

Results: 15 of 87 patients developed recurrence, with a relapse-rate of 17.2%. Statistical analysis showed a significant correlation between CRM involvement and mr-EMVI assessed in pre-nCRT MRI and the risk of recurrence; 3 years-DFS in patients positive for these two parameters was significantly shorter compared with negatives. In post-nCRT MRI, all four parameters correlated significantly with recurrence: mr-EMVI affected significantly 3 years-DFS and its regression after nCRT correlated with a trend toward improvement of survival outcomes, although not statistically significant.

Conclusions: CRM involvement and mr-EMVI assessed in pre-nCRT MRI should be considered early predictive factors of recurrence in rectal cancer. MRI performed after nCRT has a significant value in predicting risk of recurrence: mr-EMVI confirmed to be a poor prognosis predictor and its regression or persistence after nCRT could have influences on treatment and follow-up strategies.

Keywords: Extramural venous invasion (EMVI); MRI; Predictive factors; Preoperative chemoradiotherapy; Rectal cancer.

PubMed Disclaimer

References

    1. MERCURY Study Group (2006) Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 333(7572):779. https://doi.org/10.1136/bmj.38937.646400.55 - DOI - PMC
    1. MERCURY Study Group (2007) Extramural depth of tumour invasion at thin-section MR in patients with rectal cancer: results of the MERCURY Study. Radiology 243:132–139. https://doi.org/10.1148/radiol.2431051825 - DOI
    1. Nougaret S, Reinhold C, Mikhael HW, et al. (2013) The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the ‘‘DISTANCE’’? Radiology 268:330–344. https://doi.org/10.1148/radiol.13121361 - DOI - PubMed
    1. Shihab OC, Taylor F, Salerno G, et al. (2011) MRI predictive factors for long-term outcomes of low rectal tumours. Annals of Surgical Oncology 18(12):3278–3284. https://doi.org/10.1245/s10434-011-1776-2 - DOI - PubMed
    1. Bosset JF, Collette L, Calais G, et al. (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. New England Journal of Medicine 355(11):1114–1123. https://doi.org/10.1056/NEJMoa060829 - DOI - PubMed

LinkOut - more resources